Opinion · Supreme Court of the United States

Ewing v. Mytinger & Casselberry, Inc.

70 S. Ct. 870

Type
Opinion
Court
Supreme Court of the United States
Jurisdiction
Federal
Date
1950-06-05
Topic
general

noting that summary destruction of property without prior notice or hearing for the protection of public health is among “the oldest examples” of permissible government action | stating that the court has “repeatedly held that no hearing at the preliminary stage is required by due process as long as the requisite hearing is held before the final order becomes effective” | reaffirming Ewing and distinguishing it from declaratory action brought by drug manufacturers challenging FDA regulations prior to their enforcement | authorizing seizures of apparently misbranded, but physically harmless, drugs in advance of any adversary hearing | allowing seizure without a predeprivation hearing where necessary to protect the public from misbranded drugs | allowing seizure of misbranded articles by enforcement agency prior to hearing | upholding summary seizure and destruction of drugs without a predeprivation hearing | allowing seizure of misbranded articles by enforcement agency prior to hearing | upholding summary seizure and destruction of drugs without a pre-seizure hearing | authorizing seizures of apparently misbranded, but physically harmless, drugs without prior hearing | upholding seizures of misbranded articles under the Food, Drug & Cosmetics Act | prehearing seizure of misbranded articles under Federal Food & Drug Act | seizure of allegedly mislabeled drugs without hearing upheld when “there is at some stage an opportunity for a hearing and a judicial determination” | “dangerous to health . or would be in a material respect misleading to the injury or damage of the purchaser or consumer” | “It is sufficient, where only property rights are concerned, that there is at some stage an opportunity for a hearing and a judicial determination.” | potential injury to a regulated business because of seizures under the Act cannot outweigh the public interest in being protected from defective products | FDA determination of probable cause "in and of itself had no binding legal consequence” | challenged statute permitting multiple seizures of misbranded articles on a finding of probable cause by an administrator, without a hearing, is not unconstitutional under the due process clause | grand jury’s decision to indict “is conclusive on the issue of probable cause. As a result the defendant can be arrested and held for trial” without any judicial intervention | “Due process is satisfied if there is an opportunity to be heard before any final order of the agency becomes effective.” | “One of the oldest examples is the summary destruction of property without prior notice or hearing for the protection of public health" | “Judicial review of this preliminary phase of the administrative procedure does not fit the statutory scheme nor serve the policy of the [FDCA].” | “We have repeatedly held that no hearing at the preliminary stage is required by due process so long as the requisite hearing is held before the final administrative order becomes effective.” | "We have repeatedly held that no hearing at the preliminary stage is required by due process so long as the requisite hearing is held before the final administrative order becomes effective." | public interest requires summary takeover of a bank in danger of failing | upheld summary seizure and destruction of misbranded drugs without a preseizure hearing | summary seizure and destruction of misbranded drugs does not violate due process | summary seizure and destruction of misbranded drugs does not violate due process | district court lacked jurisdiction to review the FDA’s pre-seizure determination of probable cause because “[j]udicial review of this preliminary phase of the administrative procedure does not fit the statutory scheme nor serve the policy of the [FDCA]” | immediate seizure under the Federal Food, Drug and Cosmetic Act of mislabeled products which would be "misleading to the injury or damage of the purchaser or consumer" if the product were introduced into interstate commerce | s

Citator

Cited by
233 opinions